Keywords: ark, thera, loss, up, costs, uk-based, drugmaker

Ark Thera's 2006 loss up 16%, on R&D costs

Article | 19 March 2007

Print This

UK-based drugmaker Ark Therapeutics said that, for the full year ended December 31, its loss was L17.5 million ($34.0 million), up 15.9% from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in